Phase III trial of beclometasone (SGX203) in paediatric patients with Crohn's disease

Trial Profile

Phase III trial of beclometasone (SGX203) in paediatric patients with Crohn's disease

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Jan 2016

At a glance

  • Drugs Beclometasone (Primary)
  • Indications Crohn's disease
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 26 Jan 2016 According to a Soligenix media release, this trial is expected to be initiated during the first half of 2016.
    • 14 Apr 2015 Primary results are expected to be available in the first half of 2017, according to a Soligenix media release.
    • 14 Apr 2015 The US FDA has cleared the protocol for this trial, according to a Soligenix media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top